Vivakor, Inc. Files 8-K with Shareholder Votes and Disclosures
Ticker: VIVK · Form: 8-K · Filed: Sep 17, 2025 · CIK: 1450704
Sentiment: neutral
Topics: corporate-action, disclosure, filing
TL;DR
Vivakor filed an 8-K on Sep 11, reporting shareholder votes, Reg FD, and other events. Check it out.
AI Summary
Vivakor, Inc. filed an 8-K on September 17, 2025, reporting events as of September 11, 2025. The filing indicates a submission of matters to a vote of security holders, a Regulation FD disclosure, and other events, along with financial statements and exhibits. The company is incorporated in Nevada and its principal executive offices are located in Dallas, Texas.
Why It Matters
This 8-K filing signals important corporate actions and disclosures by Vivakor, Inc., which could impact investor decisions and the company's regulatory standing.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant corporate news, but the specific details of the 'matters to a vote' and 'other events' are not elaborated in this summary, requiring further investigation.
Key Players & Entities
- Vivakor, Inc. (company) — Registrant
- September 11, 2025 (date) — Earliest event reported
- September 17, 2025 (date) — Date of report
- Nevada (jurisdiction) — State of incorporation
- Dallas, TX (location) — Principal executive offices
FAQ
What specific matters were submitted to a vote of Vivakor, Inc. security holders?
The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not provided in the provided text.
What is the nature of the Regulation FD Disclosure mentioned in the filing?
The filing lists 'Regulation FD Disclosure' as an item, but the content of this disclosure is not detailed in the provided text.
What are the 'Other Events' that Vivakor, Inc. is reporting?
The filing notes 'Other Events' as a category, but the specific events are not described in the provided text.
When was Vivakor, Inc. incorporated, and where are its principal executive offices located?
Vivakor, Inc. was incorporated in Nevada and its principal executive offices are located at 5220 Spring Valley Rd. Suite 500, Dallas, TX 75254.
What is the Commission File Number for Vivakor, Inc.'s 8-K filing?
The Commission File Number for Vivakor, Inc. is 001-41286.
Filing Stats: 1,294 words · 5 min read · ~4 pages · Grade level 12.2 · Accepted 2025-09-17 17:22:06
Key Financial Figures
- $1 — mon stock had been below the minimum of $1 per share required for continued listin
Filing Documents
- vivakor_8k.htm (8-K) — 63KB
- vivakor_ex99-1.htm (EX-99.1) — 13KB
- 0001829126-25-007455.txt ( ) — 247KB
- vivk-20250911.xsd (EX-101.SCH) — 3KB
- vivk-20250911_lab.xml (EX-101.LAB) — 33KB
- vivk-20250911_pre.xml (EX-101.PRE) — 22KB
- vivakor_8k_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On September 11, 2025, Vivakor, Inc. (the "Company") held its 2025 annual meeting of stockholders (the "Annual Meeting"). The total shares voted at the meeting were 30,286,353 out of a total number of 48,051,097 shares issued and outstanding and entitled to vote at the Annual Meeting, meaning greater than 50% of the shares of common stock outstanding and entitled to vote at the Annual Meeting were present in person or by proxy thereby constituting a quorum. The results of the matters voted on by the Company's stockholders are set forth immediately below. Proposal 1 Election of the four nominees to the Company's board of directors: Name Votes For Votes Against Withheld Percentage Voted For James Ballengee 30,245,927 0 40,426 62.95 % John Harris 30,173,247 0 113,106 62.79 % Albert Johnson 29,963,223 0 323,130 62.36 % Michael Thompson 30,001,918 0 284,435 62.44 % Proposal 2 Approval of the J.J. Astor Stock Issuances, as detailed in the proxy materials: Votes For Votes Against Votes Abstained Broker Non-Votes 30,097,856 65,897 122,600 Proposal 3 Approval of the Notes Stock Issuances, as detailed in the proxy materials: Votes For Votes Against Votes Abstained Broker Non-Votes 30,079,955 66,421 139,977 Proposal 4 Approval of the Preferred Stock Issuances, as detailed in the proxy materials: Votes For Votes Against Votes Abstained Broker Non-Votes 30,025,451 126,759 134,143 1 Proposal 5 Ratification of the MEL/ET Transaction, as detailed in the proxy materials: Votes For Votes Against Votes Abstained Broker Non-Votes 30,081,244 130,423 74,686 Proposal 6 Approval of the Reverse Stock Split, as detailed in the proxy materials: Votes For Votes Against Votes Abstained Broker Non-Votes 30,068,828 187,892 29,633 Proposal 7 Ratification of the selection of Urish Popeck & Co., LLC as the Company's independent registered p
01
Item 7.01 Regulation FD Disclosure. On September 17, 2025, Vivakor issued a press release announcing Nasdaq's approval of an extension of time, through March 16, 2026, for the Company to regain compliance with Nasdaq's listing rules as described in Item 8.01 of this Form 8-K. The full text of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference in this Item 7.01. The information contained in this Item 7.01 and in the accompanying Exhibit 99.1 is deemed to be "furnished" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
01
Item 8.01 Other Events. On September 16, 2025, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it would be afforded an additional 180 calendar days (or until March 16, 2026) to regain compliance with Nasdaq's minimum bid price requirement. As previously disclosed, on March 18, 2025, the Company received an initial letter from the Nasdaq Listing Qualifications Department stating that, for the preceding 30 consecutive business days (through March 17, 2025), the closing bid price of the Company's common stock had been below the minimum of $1 per share required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) . The initial letter stated that the Company would be afforded an initial 180-day period (until September 15, 2025) to regain compliance. The initial letter also stated that, in the event the Company did not regain compliance within the initial 180-day period, the Company might be eligible for an additional 180-day period to do so . Although the Company did not regain compliance within the initial 180-day period, Nasdaq determined that the Company was eligible for the additional 180-day period to regain compliance. In order to regain compliance, the closing bid price of the Company's common stock must be at least $1 per share for a minimum of ten consecutive business days during the additional 180-day period (ending March 16, 2026). The Company intends to consider all available options to regain compliance with the Nasdaq listing standards. The Nasdaq notification has no effect at this time on the listing of the Company's common stock, which will continue to trade uninterrupted under the symbol "VIVK." 3
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Exhibit 99.1 Press Release Announcing Nasdaq Granting Extension of Time to Regain Compliance, issued September 17, 2025 1 104 Cover Page Interactive Data File (formatted as Inline XBRL document). 1 Exhibit is furnished and not filed, as described in Item 7.01. 4
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VIVAKOR, INC. Dated: September 17, 2025 By: /s/ James Ballengee Name: James Ballengee Title: Chief Executive Officer, President and Chairman of the Board 5